|
Franzoni Filati was born as Cotonificio Franzoni in 1962 and
thanks to a strategy continuously aimed at quality, service
and technological innovation today is a leader in the production
of Combed and Open End yarns, with a large presence both in
the National and European market.
During the 40 years of its history the Group knew a continuous
expansion, arriving to have its current 6 mills placed 4 in
the North of Italy, 1 in the South of Italy and 1 in the South
East of Turkey (Sanliurfa).
Today Franzoni is one of the most important spinning mills
in Europe with a turnover of more than 120 millions of Euro
and a production of about 40 millions of Kgs; Franzoni reached
this position thanks to the continuous investments in the
most sophisticated production, research and control machines
and thanks to the development of absolutely new items with
high quality.
In 1998 Franzoni introduced on the market Franzoni Futura®,
a registered trademark which represents a new range of yarns
with low hairiness and high resistance to abrasion and pilling.
In the next few years Franzoni launched also Futura® Seamless,
Futura® Organic, Futura® Performa, Futura® Multi,
Futura® MicroModal, Futura® ProModal and Futura®
Modal-Cotton, Futura® Viscosa and Futura® ProViscosa,
Futura® Flexis, a “core spun” yarn with an
elastic core, and Futura® Maximizer, the new polyester
yarn used to produce Coolmax™ and Thermolite™
Franzoni’s strategy has always been based on a great
attention to the economic aspect of production, but Franzoni
is now focusing also on service innovation and flexibility,
because the market asks for high quality, a "just in
time" service and a new marketing approach.
Franzoni is day by day more intentioned to extend its range
of products and consequently is considering to diversify its
manufactures taking into consideration that sectors where
the raw material is always cotton.
At this purpose Franzoni Filati, with the help of some University
researchers, has just adjusted some patented synthesis able
to give the cotton fiber some plus which could be of high
interest for hospital and pharmacological sectors, that means
products with antiseptic, hemostat and anesthetic features.
|